SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-23-004635
Filing Date
2023-01-18
Accepted
2023-01-18 16:54:21
Documents
2
Group Members
NQ POF V GP, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm233779d1_sc13d.htm SC 13D 55038
2 EXHIBIT 7.03 tm233779d1_ex7-03.htm EX-7.03 6420
  Complete submission text file 0001104659-23-004635.txt   63193
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-50211 | Film No.: 23534976
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD, SUITE 920 RALEIGH NC 27609 9194598620
NovaQuest Co-Investment Fund XV, L.P. (Filed by) CIK: 0001949248 (see all company filings)

IRS No.: 862410025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D